Challenges and Opportunities for Effective Cancer Immunotherapies

Por Slaney, Clare Y., Kershaw, Michael H.
Publicado no Cancers (Basel) (2020)

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

Por John, Liza B, Kershaw, Michael H, Darcy, Phillip K
Publicado em 2013

Environmental enrichment does not impact on tumor growth in mice

Por Westwood, Jennifer A, Darcy, Phillip K, Kershaw, Michael H
Publicado em 2013

The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy

Por Westwood, Jennifer A, Darcy, Phillip K, Kershaw, Michael H
Publicado no Oncoimmunology (2014)

Clinical application of genetically modified T cells in cancer therapy

Por Kershaw, Michael H, Westwood, Jennifer A, Slaney, Clare Y, Darcy, Phillip K
Publicado no Clin Transl Immunology (2014)

Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses

Por Oliver, Amanda J., Darcy, Phillip K., Kershaw, Michael H., Slaney, Clare Y.
Publicado no J Thorac Dis (2020)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

Por Devaud, Christel, John, Liza B, Westwood, Jennifer A, Darcy, Phillip K, Kershaw, Michael H
Publicado em 2013

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

Por Kershaw, Michael H, Devaud, Christel, John, Liza B, Westwood, Jennifer A, Darcy, Phillip K
Publicado em 2013

A Mutant Tat Protein Provides Strong Protection from HIV-1 Infection in Human CD4(+) T Cells

Por Apolloni, Ann, Lin, Min-Husan, Sivakumaran, Haran, Li, Dongsheng, Kershaw, Michael H.R., Harrich, David
Publicado em 2013

Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities

Por Chan, Jack D., Harrison, Aaron J., Darcy, Phillip K., Kershaw, Michael H., Slaney, Clare Y.
Publicado no J Thorac Dis (2020)

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer

Por Ali, Aesha I., Oliver, Amanda J., Samiei, Tinaz, Chan, Jack D., Kershaw, Michael H., Slaney, Clare Y.
Publicado no Front Oncol (2019)

MHC class I and class II Presentation of Tumor Antigen in Retrovirally and Adenovirally Transduced Dendritic Cells

Por Sloan, J Mark, Kershaw, Michael H, Touloukian, Christopher E, Lapointe, Rejean, Robbins, Paul F, Restifo, Nicholas P, Hwu, Patrick
Publicado em 2002

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

Por Quetglas, José I., John, Liza B., Kershaw, Michael H., Álvarez-Vallina, Luis, Melero, Ignacio, Darcy, Phillip K., Smerdou, Cristian
Publicado em 2012

Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice

Por Westwood, Jennifer A., Potdevin Hunnam, Titaina C. U., Pegram, Hollie J., Hicks, Rodney J., Darcy, Phillip K., Kershaw, Michael H.
Publicado em 2014

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses

Por Oliver, Amanda J., Lau, Peter K. H., Unsworth, Ashleigh S., Loi, Sherene, Darcy, Phillip K., Kershaw, Michael H., Slaney, Clare Y.
Publicado no Front Immunol (2018)

CD73: A potential biomarker for anti-PD-1 therapy

Por Beavis, Paul A, Slaney, Clare Y, Milenkovski, Nicole, Henderson, Melissa A, Loi, Sherene, Stagg, John, Kershaw, Michael H, Darcy, Phillip K
Publicado no Oncoimmunology (2015)

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

Por Sharkey Janelle, Guru Preethi, Darcy Phillip K, Westwood Jennifer A, Pegram Hollie J, Amos Sally M, Smyth Mark J, Kershaw Michael H
Publicado em 2010-04-01

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

Por Westwood, Jennifer A, Darcy, Phillip K, Guru, Preethi Mayura, Sharkey, Janelle, Pegram, Hollie J, Amos, Sally M, Smyth, Mark J, Kershaw, Michael H
Publicado em 2010

Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach

Por Duong, Connie P. M., Westwood, Jennifer A., Yong, Carmen S. M., Murphy, Amanda, Devaud, Christel, John, Liza B., Darcy, Phillip K., Kershaw, Michael H.
Publicado em 2013

Cross-talk between tumors can affect responses to therapy

Por Devaud, Christel, John, Liza B, Westwood, Jennifer A, Yong, Carmen SM, Beavis, Paul A, Schwendener, Reto A, Darcy, Phillip K, Kershaw, Michael H
Publicado no Oncoimmunology (2015)